Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition pdf

Author:
Edition: 2
Publisher: CRC Press
Binding: Hardcover
ISBN: 1439853886

Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition

The rapid advances in recombinant DNA technology and the increasing availability of peptides and proteins with therapeutic potential are a challenge for pharmaceutical scientists who have to formulate these compounds as drug products. Medical books Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition.

Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition discusses the development of therapeutic peptides and proteins, from the production of active compounds via basic pre-formulation and formulation to the registration of the final product Medical books Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition. Contributors: Lars Hovgaard - Editor. Format: Hardcover

Download link for "Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition"

Contributors: Lars Hovgaard - Editor. Format: Hardcover

The rapid advances in recombinant DNA technology and the increasing availability of peptides and proteins with therapeutic potential are a challenge for pharmaceutical scientists who have to formulate these compounds as drug products. Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition discusses the development of therapeutic peptides and proteins, from the production of active compounds via basic pre-formulation and formulation to the registration of the final product. Providing integrated solutions, this book discusses: The synthesis of peptides and the biotechnol

Medical Book Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition

Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition discusses the development of therapeutic peptides and proteins, from the production of active compounds via basic pre-formulation and formulation to the registration of the final product.

Providing integrated solutions, this book discusses:

• The synthesis of peptides and the biotechnological production of proteins through recombinant DNA technology
• The physicochemical characteristics and stability of peptides and proteins
• The formulation of proteins as suspensions, solutions, and (mostly freeze-dried) solids
• The opportunities and challenges of non-parenteral delivery of peptides and proteins
• Risk factors, specifically the development of an unwanted immune response
• A simulation approach to describe the fate of peptides and proteins upon administration to a biological system
• The documentation required to register a protein-based drug

Scientists in the pharmaceutical industry and academia as well as postgraduate students in pharmaceutical science will find this a valuable resource.

Water-Insoluble Drug Formulation, Second Edition

Author:
Edition: 2
Publisher: CRC Press
Binding: Hardcover
ISBN: 0849396441

Water-Insoluble Drug Formulation, Second Edition

Scientists have attributed more than 40 percent of the failures in new drug development to poor biopharmaceutical properties, particularly water insolubility. Medical books Water-Insoluble Drug Formulation, Second Edition. Issues surrounding water insolubility can postpone, or completely derail, important new drug development. Even much-needed reformulation of currently marketed products can be significantly affected by these challenges.

Water Insolubility is the Primary Culprit in over 40% of New Drug Development Failures

The most comprehensive resource on the topic, this second edition of Water Insoluble Drug Formulation brings together a distinguished team of experts to provide the scientific background and step-by-step guidance needed to deal with solubility issues in drug development. Twenty-three chapters systematically describe solubility properties and their impact on formulation, from theory to industrial practice Medical books "Water-Insoluble Drug Formulation, Second Edition". "Scientists have attributed more than 40 percent of the failures in new drug development to poor biopharmaceutical properties, particularly water insolubility. Issues surrounding water insolubility can postpone, or completely derail, important new drug development. Even much-needed reformulation of currently marketed products can be significantly affected by these challenges. Water Insolubility is the Primary Culprit in over 40% of New Drug Development Failures The most comprehensive resource on the topic, this second edition of Water Insoluble Drug Formulation brings together a distinguished team of experts to provide the scientific background and step-by-step guidance needed to deal with solubility issues in drug development. Twenty-three chapters systematically describe solubility properties and their impact on formulation, from theory to industrial practice. With detailed discussion on how these properties contribute to solubilization and dissolution, the text also features six brand new chapters on water-insoluble drugs, exploring regulatory aspects, pharmacokinetic behavior, early phase formulation strategies, lipid based systems for oral delivery, modified release of insoluble drugs, and scalable manufacturing aspects. The book includes more than 15 water-insoluble drug delivery systems or technologies, illustrated with case studies featuring oral and parenteral applications. Highlighting the most current information and data available, this seminal volume reflects the significant progress that has been made in nearly all aspects of this field.File Size: 13183 KBPrint Length: 688 pagesPublisher: CRC Press; 2 edition (May 14, 2012) Sold by: Amazon Digital Services, Inc.Language: EnglishASIN: B00866HFXU"

Download link for Water-Insoluble Drug Formulation, Second Edition

"Scientists have attributed more than 40 percent of the failures in new drug development to poor biopharmaceutical properties, particularly water insolubility. Issues surrounding water insolubility can postpone, or completely derail, important new drug development. Even much-needed reformulation of currently marketed products can be significantly affected by these challenges. Water Insolubility is the Primary Culprit in over 40% of New Drug Development Failures The most comprehensive resource on the topic, this second edition of Water Insoluble Drug Formulation brings together a distinguished

"Scientists have attributed more than 40 percent of the failures in new drug development to poor biopharmaceutical properties, particularly water insolubility. Issues surrounding water insolubility can postpone, or completely derail, important new drug development. Even much-needed reformulation of currently marketed products can be significantly affected by these challenges. Water Insolubility is the Primary Culprit in over 40% of New Drug Development Failures The most comprehensive resource on the topic, this second edition of Water Insoluble Drug Formulation brings together a distinguished

"Scientists have attributed more than 40 percent of the failures in new drug development to poor biopharmaceutical properties, particularly water insolubility. Issues surrounding water insolubility can postpone, or completely derail, important new drug development. Even much-needed reformulation of currently marketed products can be significantly affected by these challenges. Water Insolubility is the Primary Culprit in over 40% of New Drug Development Failures The most comprehensive resource on the topic, this second edition of Water Insoluble Drug Formulation brings together a distinguished

"Scientists have attributed more than 40 percent of the failures in new drug development to poor biopharmaceutical properties, particularly water insolubility. Issues surrounding water insolubility can postpone, or completely derail, important new drug development. Even much-needed reformulation of currently marketed products can be significantly affected by these challenges. Water Insolubility is the Primary Culprit in over 40% of New Drug Development Failures The most comprehensive resource on the topic, this second edition of Water Insoluble Drug Formulation brings together a distinguished

Medical Book Water-Insoluble Drug Formulation, Second Edition

Issues surrounding water insolubility can postpone, or completely derail, important new drug development. Even much-needed reformulation of currently marketed products can be significantly affected by these challenges.

Water Insolubility is the Primary Culprit in over 40% of New Drug Development Failures

The most comprehensive resource on the topic, this second edition of Water Insoluble Drug Formulation brings together a distinguished team of experts to provide the scientific background and step-by-step guidance needed to deal with solubility issues in drug development. Twenty-three chapters systematically describe solubility properties and their impact on formulation, from theory to industrial practice. With detailed discussion on how these properties contribute to solubilization and dissolution, the text also features six brand new chapters on water-insoluble drugs, exploring regulatory aspects, pharmacokinetic behavior, early phase formulation strategies, lipid based systems for oral delivery, modified release of insoluble drugs, and scalable manufacturing aspects. The book includes more than 15 water-insoluble drug delivery systems or technologies, illustrated with case studies featuring oral and parenteral applications. Highlighting the most current information and data available, this seminal volume reflects the significant progress that has been made in nearly all aspects of this field.

Oral Controlled Release Formulation Design and Drug Delivery pdf

Author:
Edition: 1
Publisher: Wiley
Binding: Hardcover
ISBN: 0470253177

Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice

This book describes the theories, applications, and challenges for different oral controlled release formulations. Medical books Oral Controlled Release Formulation Design and Drug Delivery. This book differs from most in its focus on oral controlled release formulation design and process development Medical books Oral Controlled Release Formulation Design And Drug Delivery Ebook. Buy Oral Controlled Release Formulation Design and Drug Delivery by and Read this Book on Kobo's Free Apps. Discover Kobo's Vast Collection of Ebooks Today - Over 3 Million Titles, Including 2 Million Free Ones!

Download link for Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice

Buy Oral Controlled Release Formulation Design and Drug Delivery by and Read this Book on Kobo's Free Apps. Discover Kobo's Vast Collection of Ebooks Today - Over 3 Million Titles, Including 2 Million Free Ones!

Oral Controlled Release Formulation Design and Drug Delivery

"This book describes the theories, applications, and challenges for different oral controlled release formulations. This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro-in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues.File Size: 8961 KBPrint Length: 376 pagesPublisher: Wiley; 1 edition (May 9, 2011) Sold by: Amazon Digital Services, Inc.Language: EnglishASIN: B0050KCPD0"

"This book describes the theories, applications, and challenges for different oral controlled release formulations. This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro-in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues"--Provided by publisher.

Medical Book Oral Controlled Release Formulation Design and Drug Delivery

This book differs from most in its focus on oral controlled release formulation design and process development. It also covers the related areas like preformulation, biopharmaceutics, in vitro-in vivo correlations (IVIVC), quality by design (QbD), and regulatory issues.

Protein Formulation and Delivery pdf

Author:
Edition: 2
Publisher: CRC Press
Binding: Hardcover
ISBN: 0849379490

Protein Formulation and Delivery (Drugs and the Pharmaceutical Sciences)

This title is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Medical books Protein Formulation and Delivery . Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed Medical books Protein Formulation and Delivery. Categories: Drug Design, Proteins, Protein Structure. Contributors: Taylor and Francis - Author. Format: Hardcover

Download link for Protein Formulation and Delivery (Drugs and the Pharmaceutical Sciences, Volume 99)

Categories: Drug Design, Proteins, Protein Structure. Contributors: Taylor and Francis - Author. Format: Hardcover

Categories: Drug Design, Proteins, Protein Structure. Contributors: Taylor and Francis - Author. Format: Hardcover

Boehringer Ingelheim Pharmaceuticals Inc Ridgefield CT Directs scientists new to the field of protein formulation to appropriate starting points for development processes Emphasizes the selection of conditions excipients and container closure systems

Categories: Drug Design, Drug delivery systems. Contributors: Eugene J. McNally - Editor. Format: Hardcover

Medical Book Protein Formulation and Delivery

Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed. Because many developments in the field have emerged since the publication of the First Edition, this Second Edition addresses important new patient-friendly developments in the field, such as formulation for implantable devices, needle-free formulation and delivery approaches, and oral delivery of proteins.